The gene behind the disease

December 22, 2021 7:11 am Published by Leave your thoughts

The Genoox platform was used by Teva as part of cohort analysis looking for a genetically-validated drug target for the treatment of pain phenotypes.

Categorised in:

This post was written by admin

Leave a Reply

Your email address will not be published. Required fields are marked *